Daniel H. Ahn
Impact in
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Peptidase Inhibition and Analysis
- Hepatology top 5%
Papers in
- Co-authors
- Tanios Bekaii‐Saab (105 shared papers)Stanley Lu (2 shared papers)Glyn Johnson (2 shared papers)Mitesh J. Borad (41 shared papers)Soonmee Cha (1 shared paper)Milind Javle (15 shared papers)Rachna T. Shroff (10 shared papers)Ahmed O. Kaseb (6 shared papers)
- Journals
- Journal of Clinical Oncology (44 papers)The Oncologist (10 papers)Annals of Oncology (10 papers)Cancers (5 papers)Cancer Research (5 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Daniel H. Ahn
141 papers receiving 3.7k citations
Daniel H. Ahn's Hit Papers
Peers
Comparison fields: 5 of 98
- Oncology 2.0k
- Hepatology 283
- Cancer Research 527
- Surgery 1.5k
- Pathology and Forensic Medicine 520
Countries citing papers authored by Daniel H. Ahn
This map shows the geographic impact of Daniel H. Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel H. Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel H. Ahn more than expected).
Fields of papers citing papers by Daniel H. Ahn
This network shows the impact of papers produced by Daniel H. Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel H. Ahn. The network helps show where Daniel H. Ahn may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel H. Ahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 153 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers Hit paper breakdown → | 2019 | 321 |
| 2 | Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. | 2003 | 293 |
| 3 | 2016 | 289 | |
| 4 | 2004 | 241 | |
| 5 | 2019 | 181 | |
| 6 | 2020 | 137 | |
| 7 | 2018 | 123 | |
| 8 | 2016 | 119 | |
| 9 | 2015 | 100 | |
| 10 | 2017 | 90 | |
| 11 | 2014 | 75 | |
| 12 | 2015 | 69 | |
| 13 | 2019 | 69 | |
| 14 | 2019 | 61 | |
| 15 | 2015 | 60 | |
| 16 | 2019 | 54 | |
| 17 | 2018 | 54 | |
| 18 | 2013 | 52 | |
| 19 | 2017 | 48 | |
| 20 | The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene. | 2002 | 47 |
About Daniel H. Ahn
Daniel H. Ahn is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology, having authored 153 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (48 papers), Pancreatic and Hepatic Oncology Research (45 papers), Colorectal Cancer Treatments and Studies (41 papers), Cancer Genomics and Diagnostics (33 papers), Cancer Treatment and Pharmacology (17 papers), Genetic factors in colorectal cancer (14 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Gallbladder and Bile Duct Disorders (12 papers). The work is most often cited by research in Oncology (2.0k citations), Hepatology (283 citations), Cancer Research (527 citations), Surgery (1.5k citations) and Pathology and Forensic Medicine (520 citations). Daniel H. Ahn has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Tanios Bekaii‐Saab, Stanley Lu, Glyn Johnson, Mitesh J. Borad, Soonmee Cha, Milind Javle, Rachna T. Shroff, Ahmed O. Kaseb, Mohamad Bassam Sonbol and Ramesh K. Ramanathan. Their work appears in journals such as Journal of Clinical Oncology, The Oncologist, Annals of Oncology, Cancers and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.